23:04:47 EST Wed 11 Dec 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:BCT - BRIACELL THERAPEUTICS CORP. J - http://www.briacell.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BCT - T  0.71.48·1.6512.01.59+0.063.9134.11874551.55  1.63  1.428.00  0.6416:00:0019:5715 min RT 2¢
TSX - T0.71.48·1.6512.01.59+0.063.992.41293051.55  1.63  1.428.00  0.6416:00:0015 min
NEO ATS - U 1.56+0.032.03.04151.47  1.59  1.4715:35:5215 min
Alpha - A 1.59+0.063.920.631171.56  1.62  1.5315:23:0615 min
Omega - O 1.54+0.010.70.3011.54  1.54  1.5412:56:3715 min
Pure - P 1.56+0.032.01.72171.50  1.60  1.4315:35:5215 min
Chi-X - X 1.55+0.021.310.514471.54  1.61  1.4315:53:0515 min
CX2 - H 1.56+0.032.01.9391.50  1.56  1.4715:35:2115 min
CXD - D 1.625+0.0956.21.31151.51  1.625  1.5114:10:2615 min
TriAct - M 1.531.7223    Sep 11-2015 min
CS2 - S 1.54+0.010.70.7161.53  1.54  1.5312:56:3715 min

Recent Trades - Last 10 of 455
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T1.590.061001 Anonymous79 CIBCKQ
15:59:59T1.540.0110079 CIBC79 CIBCK
15:59:01M1.560.037879 CIBC79 CIBCE
15:53:05X1.550.0210079 CIBC79 CIBCK
15:52:05X1.550.0210079 CIBC79 CIBCK
15:52:05X1.550.0210079 CIBC79 CIBCK
15:51:19X1.550.0210079 CIBC79 CIBCK
15:51:19X1.550.0230079 CIBC79 CIBCK
15:51:19T1.560.0310080 National Bank79 CIBCK
15:51:19T1.550.0210079 CIBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-12-11 19:57C:BCT1.59News ReleaseBriacell Therapeutics arranges public offering
2024-12-11 17:16C:BCT1.59News ReleaseBriacell presents MBC survival data in Spotlight poster
2024-12-02 18:27C:BCT1.56News ReleaseBriacell gets green light from DSMB for phase 3 study
2024-11-26 07:50C:BCT0.94News ReleaseBriaCell 2024 SABCS(TM) Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer
2024-11-25 16:20C:BCT0.94News ReleaseBriacell director Lustig resigns
2024-11-21 16:05C:BCT0.85News ReleaseBriacell doses first patient in Bria-OTS study
2024-11-08 07:50C:BCT0.97News ReleaseBriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
2024-11-04 07:50C:BCT1.10News ReleaseBriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium(TM), December 10 - 13
2024-10-28 15:54C:BCT1.21SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-10-28 15:53C:BCT1.21SEDAR Annual ReportSEDAR Annual Report
2024-10-28 15:48C:BCT1.21SEDAR MD & ASEDAR MD & A
2024-10-22 15:01C:BCT1.11News ReleaseBriacell sees 55% survival rate in one-year patients
2024-10-15 15:20C:BCT1.34News ReleaseBriacell to complete patient enrolment in mid-2025
2024-10-02 16:43C:BCT1.33News ReleaseBriacell closes $5-million offering
2024-10-01 14:56C:BCT1.63News ReleaseBriacell Therapeutics arranges $5-million offering
2024-10-01 14:49C:BCT1.63News ReleaseBriacell boasts of full resolution in cancer patient
2024-09-18 13:42C:BCT0.65News ReleaseBriacell receives FDA authorization for access policy
2024-09-12 17:04C:BCT0.84News ReleaseBriacell Therapeutics closes $8.5-million financing
2024-09-11 16:13C:BCT0.84News ReleaseBriacell arranges $8.5-million private placement
2024-09-11 14:49C:BCT0.87News ReleaseBriacell boasts of 15.6-month median survival data